GSK plc

Q1 2026 13F-HR Holdings

Location
London, X0
Holdings as of
3/31/2026
Date filed
5/14/2026
Form type
13F-HR
Num holdings
13
Total value ($000)
$599,153
Net value change ($000)
-199,870 (-25.0%)
New positions
0
Sold out positions
2
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/12/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q4 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
VIR 25,055 48.6%
CVRX 2,378 33.2%
NKTX 819 14.1%
CYTK 807 3.7%
SPRO 92 0.4%
Top Reduces (Value $000, Stocks/ETFs)
WAVE LIFE SCIENCES LTD -177,896 -57.4%
LYEL -16,216 -34.8%
CRSP -15,685 -9.3%
FULC -6,500 -32.2%
BNTX -5,623 -6.6%
BCYC -3,732 -34.5%
IDYA -1,666 -3.6%
RGNX -1,634 -41.8%
SENS -60 -100.0%
HBIO -7 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type